Analgesia and abuse potential: An accidental association or a common substrate?

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 4, 1998, Pages 993-1002

  Franklin, K B J ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Amphetamines; Analgesia; Cannabinoids; Dopamine; GABA; NMDA antagonists; Opioids; Reinforcement; Serotonin; Substance abuse

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; AMPHETAMINE; ANALGESIC AGENT; MORPHINE;

ANALGESIA; ARTICLE; DRUG ABUSE; DRUG MECHANISM; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

EID: 0032052747     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00535-2     Document Type: Article

References (176)

1. Abbott F. V., Franklin K. B. J. Noncompetitive antagonism of morphine analgesia by diazepam in the formalin test. Pharmacol. Biochem. Behav. 24:1986;319-321.
2. Abbott F. V., Franklin K. B. J., Connell B. The stress of a novel environment reduces formalin pain. Possible role of serotonin Eur. J. Pharmacol. 126:1986;141-144.
3. Abbott F. V., Franklin K. B. J., Westbrook R. F. The formalin test. Scoring properties of the first and second phases of the pain response in rats Pain. 60:1995;91-102.
4. Abbott, F. V.; Fraser, M.: Use and abuse of over-the-counter analgesic agents. J. Psychiatr. Neurosci. (in press).
5. 2A receptors potentiates pain produced by inflammatory mediators. Neuropharmacology. 35:1996;99-110.
6. Abbott F. V., Hong Y., Franklin K. B. J. The effect of lesions of the dorsolateral funiciculus on formalin pain and morphine analgesia. A dose-response analysis Pain. 65:1996;17-23.
7. Abbott F. V., Young S. N. Effect of 5-hydroxytryptamine precursors on morphine analgesia in the formalin test. Pharmacol. Biochem. Behav. 31:1988;855-860.
8. Aceto M. D., Bagley R. S., Dewey W. L., Fu T. C., Martin B. R. The spinal cord as a major site for the antinociceptive action of nicotine in the rat. Neuropharmacology. 25:1986;1031-1036.
9. Akil H., Watson S. J., Young E., Lewis M. E., Khachaturian H., Walker J. M. Endogenous opioids. Biology and function Annu. Rev. Neurosci. 7:1984;223-255.
10. Altier N., Stewart J. Intra-VTA infusions of the substance P analogue, DiMe-C7, and intra-accumbens infusions of amphetamine induce analgesia in the formalin test for tonic pain. Brain Res. 628:1993;279-285.
11. Altier, N.; Stewart, J.: Tachykinin NK-1 and NK-3 selective agonists induce analgesia in the formalin test for tonic pain following intra-VTA or intra-accumbens microinfusions. Brain Res. (in press).
12. Appelbaum B. D., Holtzman S. G. Characterization of stress-induced potentiation of opioid effects in the rat. J. Pharmacol. Exp. Ther. 231:1984;555-565.
13. Ator N. A., Griffiths R. R. Self-administration of barbiturates and benzodiazepines. A review Pharmacol. Biochem. Behav. 27:1987;391-397.
14. Baber N. S., Dourish C. T., Hill D. R. The role of CCK caerulein, and CCK antagonists in nociception. Pain. 39:1989;307-328.
15. Bals-Kubik R., Herz A., Shippenberg T. S. Evidence that the aversive effects of opioid antagonists and K-agonists are centrally mediated. Psychopharmacology (Berlin). 98:1989;203-206.
16. Balster R. L., Schuster C. R. Fixed-interval schedule of cocaine reinforcement. Effect of dose and infusion duration J. Exp. Anal. Behav. 20:1973;119-129.
17. Bartolini A., Galli A., Ghelardini C., Giotti A., Malcangio M., Malmberg-Aiello P., Zucchi P. L. Antinociception induced by systemic administration of local anaesthetics depends on a central cholinergic mechanism. Br. J. Pharmacol. 92:1987;711-721.
18. Basbaum A. I., Fields H. L. Endogenous pain control mechanisms. Brainstem pathways and endorphin circuitry Annu. Rev. Neurosci. 7:1984;309-338.
19. Baumeister A., Advokat C. Evidence for a supraspinal mechanism in the opioid-mediated antinociceptive effect of ketamine. Brain Res. 566:1991;351-353.
20. Bechara A., van der Kooy D. Kappa receptors mediate the peripheral aversive effects of opiates. Pharmacol. Biochem. Behav. 28:1987;227-233.
21. Beecher H. K. Measurement of subjective responses. Quantitative effects of drugs:1959;Oxford University Press, New York.
22. Belvisi M. G., Rogers D. F., Barnes P. J. Neurogenic plasma extravasation. Inhibition by morphine in guinea pig airways in vivo J. Appl. Physiol. 66:1989;268-272.
23. Ben-Sreti M. M., Gonzales J. P., Sewell R. D. E. Differential effects of SKF 38393 and LY 141865 on nociception and morphine analgesia. Life Sci. 33(Suppl. 1):1983;665-668.
24. Bodnar R. J., Nicotera N. Neuroleptic and analgesic interactions upon pain and activity meausures. Pharmacol. Biochem. Behav. 16:1982;411-416.
25. Borszcz G. S., Johnson C. P., Thorp M. V. The differential contribution of spinopetal projections to increases in vocalization and motor reflex thresholds generated by the microinjection of morphine into the periaqueductal gray. Behav. Neurosci. 110:1996;368-388.
26. Bozarth M. A., Wise R. A. Intracranial self-administration of morphine into the ventral tegmental area of rats. Life Sci. 28:1981;551-555.
27. Burrill D. Y., Goetzl F. R., Ivy A. C. The pain threshold raising effects of amphetamine. J. Dent. Res. 23:1944;337-344.
28. Calcagnetti D. J., Holtzman S. G. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine. Pharmacol. Biochem. Behav. 38:1991;185-190.
29. Carlini E. A. Preliminary note. Dangerous use of anticholinergic drugs in Brazil Drug Alcohol Depend. 32:1993;1-7.
30. Carlsson K.-H., Jurna I. Interaction of pentobarbital and morphine in the tail-flick test performed on rats. Synergism at the spinal and antagonism at the supraspinal level Neurosci. Lett. 71:1986;356-360.
31. Carmody J., Jamieson D., Depoortere R. Opioid-independent hyperalgesia induced in mice by pentobarbitone at low dosage. Naunyn Schmiedebergs Arch. Pharmacol. 334:1986;193-195.
32. Carroll M. E., Lac S. T., Asencio M., Kragh R. Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 35:1990;237-244.
33. Carroll M. N., Lim R. K. S. Observations on the neuropharmacology of morphine and morphinelike analgesia. Arch. Int. Pharmacodyn. Ther. 125:1960;383-403.
34. Cashman J. N. The mechanisms of action of NSAIDs in analgesia. Drugs. 52(Suppl. 5):1996;13-23.
35. Castillo R., Kissin I., Bradley E. L. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression. Anesth. Analg. 65:1986;350-354.
36. Cazala P. Dose-dependent effects of morphine differentiate self-administration elicited from lateral hypothalamus and mesencephalic central gray area in mice. Brain Res. 527:1990;280-285.
37. Clarke P. B. S., Franklin K. B. J. Infusions of 6-hydroxydopamine into the nucleus accumbens abolish the analgesic effect of amphetamine but not of morphine in the formalin test. Brain Res. 580:1992;106-110.
38. Clint B. D., Lipton J. M., Giesecke A. H. Jr. Analgesic and cardiovascular effects of centrally administered substance P. Peptides. 9:1988;619-623.
39. Collins R. J., Weeks J. R., Cooper M. M., Good P. I., Russell R. R. Prediction of abuse liability of drugs using IV self-administration by rats. Psychopharmacology (Berlin). 82:1984;6-13.
40. Corrigall W. A., Clarke P. B. S., Franklin K. B. J., Coen K. M. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berlin). 107:1992;285-289.
41. D'Armour F. E., Smith D. L. A method for determining loss of pain sensation. J. Pharmacol. 72:1941;74-79.
42. Davis W. M., Smith S. G. Catecholaminergic mechanisms of reinforcement. Direct assessment by drug self-administration Life Sci. 20:1977;483-492.
43. Deneau G., Yanagita T., Seevers M. H. Self-administration of psychoactive substances by the monkey. Psychopharmacology (Berlin). 16:1969;30-48.
44. Depoortere R. Y., Li D. H., Land J. D., Emmett-Oglesby M. W. Parameters of self-administration of cocaine in rats under a progressive ratio schedule. Pharmacol. Biochem. Behav. 45:1993;539-548.
45. Devine D. P., Wise R. A. Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J. Neurosci. 14:1994;1978-1984.
46. Donny E. C., Caggiula A. R., Knopf S., Brown C. Nicotine self-administration in rats. Psychopharmacology (Berlin). 122:1995;390-394.
47. Dundee J. W. Alteration of response to somatic pain associated with anaesthesia. II. The effect of thiopentone and pentobarbitone. Br. J. Anaesth. 32:1960;407-414.
48. Dundee J. W., Gupta P. K., Jones C. J. Modification of the analgesic action of pethidine and morphine by three opiate antagonists, a respiratory stimulant (doxapram) and an analeptic (niketh(?) amide); A study using experimental pain stimulus in man. Br. J. Pharmacol. 48:1973;326.
49. Dy E. C., Yates W. R. Atypical drug abuse. A case report involving clonidine Am. Family Phys. 54:1996;1035-1038.
50. Eisenach J. C., Lysak S. Z., Viscomi C. M. Epidural clonidine analgesia following surgery. Phase I Anesthesiology. 71:1989;640-646.
51. Evans W. O. The effect of stimulant drugs on opiate induced analgesia. Arch. Biol. Med. Exp. 4:1967;144-149.
52. Fang F. G., Fields H. L., Lee N. M. Action at mu receptor is sufficient to explain the supraspinal analgesic effects of opiates. J. Pharmacol. Exp. Ther. 238:1986;1039-1043.
53. Fasmer O. B., Berge O. G., Hole K. Changes in nociception after lesions of descending serotonergic pathways induced with 5,6-dihydroxytryptamine. Different effects in the formalin and tail flick tests Neuropharmacology. 24:1985;729-734.
54. Fennessy M. R., Sawynok J. The effect of benzodiazepines on the analgesic effects of morphine, and sodium salicylate. Arch. Int. Pharmacodyn. Ther. 204:1973;77-85.
55. Fenton H. M., Liebman J. M. Self-stimulation response decrement patterns differentiate clonidine, baclofen and dopamine antagonists from drugs causing performance deficit. Pharmacol. Biochem. Behav. 17:1982;1207-1212.
56. Fertig J. B., Pomerleau O. F., Sanders B. Nicotine-produced antinociception in minimally deprived smokers and ex-smokers. Addict. Behav. 11:1986;239-248.
57. Fields H. L., Heinricher M. H., Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu. Rev. Neurosci. 14:1991;219-245.
58. France C. P., Snyder A. M., Woods J. M. Analgesic effects of phencyclidine-like drugs in rhesus monkeys. J. Pharmacol. Exp. Ther. 250:1989;197-201.
59. Franklin K. B. J. Analgesia and the neural substrate of reward. Neurosci. Biobehav. Rev. 35:1989;157-163.
60. Franklin K. B. J. Dopaminergic drugs as analgesics. Sawynok J., Cowan A. Novel aspects of pain management. Opioids and beyond:1997;Wiley, New York.
61. A receptors Pharmacol. Biochem. Behav. 46:1993;661-666.
62. Franklin K. B. J., Abbott F. V., English M. J. M., Jeans M. E., Tasker R. A. R., Young S. N. Tryptophan-morphine interactions and postoperative pain. Pharmacol. Biochem. Behav. 35:1990;157-163.
63. Gardner E. L., Lowinson J. H. Marijuana's interaction with brain reward systems. An update 1991 Pharmacol. Biochem. Behav. 40:1991;571-580.
64. Gayawali K., Pandhi P., Sharma P. L. Determination of the optimal analgesia-potentiating dose of caffeine and a study of its effect on the pharmacokinetics of aspirin in mice. Methods Find. Exp. Clin. Pharmacol. 13:1991;529-533.
65. Gelgor L., Cartwell S., Mitchell D. Intracranial micro-injections of nonsteroidal anti-inflammatory drugs abolish reperfusion hyperalgesia in the rat's tail. Pain. 50:1992;323-329.
66. Ghelardini C., Malmberg-Aiello P., Giotti A., Malcangio M., Bartolini A. Investigation into atropine-induced antinociception. Br. J. Pharmacol. 101:1990;49-54.
67. 3 receptor antagonists reduce imflammatory pain in rats. Eur. J. Pharmacol. 170:1989;83-86.
68. Glick S. D., Cox R. D. Changes in morphine self-administration after brainstem lesions in rats. Psychopharmacology (Berlin). 52:1977;151-156.
69. Goldberg S. R., Henningfield J. E. Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of IV drug injection. Pharmacol. Biochem. Behav. 30:1988;227-234.
70. Goldberg S. R., Spealman R. D., Goldberg D. M. Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science. 214:1981;573-575.
71. Gordon N. C., Heller P. H., Gear R. W., Levine J. D. Interactions between fluoxetine and opiate analgesia for postoperative dental pain. Pain. 58:1994;85-88.
72. Griffiths R. R., Lamb R. J., Sannerud C. A., Ator N. A., Brady J. V. Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons. Psychopharmacology (Berlin). 103:1991;154-161.
73. Griffiths R. R. Relative abuse liability of triazolam. Experimental assessment in animals and humans Neurosci. Biobehav. Rev. 9:1985;133-151.
74. Groppetti A., Braga P. C., Biella G., Parenti M., Rusconi L., Mantegazza P. Effect of aspirin on serotonin and Met-enkephalin in brain. Correlation with the antinociceptive activity of the drug Neuropharmacology. 27:1988;499-505.
75. Gunne L. M., Anggard E., Jönsson L. E. Clinical trials with amphetamine-blocking drugs. Psychiatr. Neurol. Neurochir. (Amst.). 75:1972;225-226.
76. Henningfield J. E., Goldberg S. R. Nicotine as a reinforcer in human subjects and laboratory animals. Pharmacol. Biochem. Behav. 19:1983;989-992.
77. Henningfield J. E., Goldberg S. R. Pharmacologic determinants of tobacco self-administration in humans. Pharmacol. Biochem. Behav. 30:1988;221-226.
78. Herz A. Endogenous opioid systems and alcohol abuse. Psychopharmacology (Berlin). 129:1997;99-111.
79. Higgins G. A. Morphine place conditioning is differentially affected by CCK-sub(A) and CCK-sub(B) receptor antagonists. Brain Res. 572:1992;208-215.
80. Higgins G. A. The CCK-sub(A) receptor antagonist devazepide does not modify opioid self-administration or drug discrimination. Comparison with the dopamine antagonist haloperidol Brain Res. 640:1994;246-254.
81. Hill H. E., Kornetsky C. H., Flanary H. G., Wikler A. Effects of anxiety and morphine on discrimination of intensities of painful stimuli. J. Clin. Invest. 31:1952;473-480.
82. Hill R. C., Maurer R., Buescher H. H., Roemer D. Analgesic properties of the GABA-mimetic THIP. Eur. J. Pharmacol. 69:1981;221-224.
83. 2 receptor antagonists on the establishment of agonist-induced place conditioning in rats. Pharmacol. Biochem. Behav. 33:1989;273-279.
84. Hoffmeister F., Wuttke W. Self-administration of acetylsalicylic acid and combinations with codeine and caffeine in rhesus monkeys. J. Pharmacol. Exp. Ther. 186:1973;266-275.
85. Hong Y., Abbott F. V. Peripheral opioid modulation of pain and inflammation in the formalin test. Eur. J. Pharmacol. 277:1995;21-28.
86. Ivy A. C., Goetzl F. R., Burrill D. Y. Morphine-dextroamphetamine analgesia. War Med. 6:1944;67-71.
87. Iwamoto E. T. Antinociception after nicotine administration into the mesopontine tegmentum of rats. Evidence for muscarinic actions J. Pharmacol. Exp. Ther. 251:1989;412-421.
88. Jaffe J. H., Martin W. R. Opioid agonists and antagonists. Gilman A. G., Rall T. W., Nies A. S., Taylor P. Goodman and Gilman's the pharmacological basis of therapeutics. 1990;485-519 Pergamon, New York.
89. Jasinski D. R., Preston K. Evaluation of mixtures of morphine and D-amphetamine for subjective and physiological effects. Drug Alcohol Depend. 17:1986;1-13.
90. Jasmin L., Carstens E., Basbaum A. I. Interneurons presynaptic to rat tail-flick motoneurons as mapped by transneuronal transport of pseudorabies virus - few have long ascending collaterals. Neuroscience. 76:1997;859-876.
91. Jebeles J. A., Kissin I., Bradley E. L. Spinal and supraspinal mechanisms for morphine-pentobarbital antinociceptive interaction in relation to cardiac acceleration response in rats. Anesth. Analg. 65:1986;601-604.
92. Keats A. S., Telford J., Kurosu Y. Potentiation of meperidine by promethazine. Anesthesiology. 22:1961;31-41.
93. Kelly S. J., Franklin K. B. J. Evidence that stress augments morphine analgesia by increasing brain tryptophan. Neurosci. Lett. 44:1984;305-310.
94. Kelly S. J., Franklin K. B. J. Electrolytic raphe magnus lesions block analgesia induced by a stress-morphine interaction but not analgesia induced by morphine alone. Neurosci. Lett. 52:1984;147-152.
95. Khroyan T. V., Baker D. A., Neisewander J. L. Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning. Psychopharmacology (Berlin). 122:1995;351-357.
96. Kleber H. D., Gold M. S. Use of psychotropic drugs in treatment of methadone maintained narcotic addicts. Ann. NY Acad. Sci. 311:1978;81-96.
97. Koob G. T., Vaccarino F. J., Amalric M., Swerdlow N. R. Neural substrates for cocaine and opiate reinforcement. Fisher S., Raskin A., Uhlenhuth E. H. Cocaine. Clinical and biobehavioral aspects:1987;80-108 Oxford University Press, New York.
98. Krappmann P., Hasenohrl R. U., Frisch C., Huston J. P. Self-administration of neurokinin substance P into the ventromedial caudate-putamen in rats. Brain Res. 628:1994;1093-1101.
99. Laska E. M., Sunshine A., Mueller F., Elvers W. B., Siegel C., Rubin A. Caffeine as an analgesic adjuvant. JAMA. 251:1984;1711-1718.
100. Le Bars D., Dickenson A. H., Besson J. M. Opiate analgesia and descending control systems. Bonica J. J.et al. Advances in pain research and therapy, vol. 5. 1983;341-372 Raven Press, New York.
101. Lecesse A. P., Lyness W. H. The effects of putative 5-hydroxytryptamine receptor active agents on d-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine medial forebrain bundle lesions. Brain Res. 303:1984;153-162.
102. Le Magnen J., Marfaing-Jallat P., Miceli D., Devos M. Pain modulating and reward systems. A single brain mechanism Pharmacol. Biochem. Behav. 12:1980;729-733.
103. Lepore M., Vorel S. R., Lowinson J., Gardner E. L. Conditioned place preference induced by delta(9)-tetracannabinol - Comparison with cocaine, morphine and food reward. Life Sci. 56:1995;2073-2080.
104. Lopez M., Peper S., Kamenka J.et al. A comparison of the reinforcing efficacy of PCP, the PCP derivatives TCP and BTCP, and cocaine using a progressive ratio schedule in the rat. Behav. Pharmacol. 6:1995;223-228.
105. Lyness W. H., Friedle N. M., Moore K. E. Increased self-administration of d-amphetamine after destruction of 5-hydroxytryptaminergic nerves. Pharmacol. Biochem. Behav. 12:1980;937-941.
106. Lyness W. H., Smith F. L., Heavner J. E., Iacono C. U., Garvin R. D. Morphine self-administration in the rat during adjuvant-induced arthritis. Life Sci. 45:1989;2217-2224.
107. Malcolm R., Brady K. T., Johnston A. L., Cunningham M. Types of benzodiazepines abused by chemically dependent inpatients. J. Psychoact. Drugs. 25:1993;315-319.
108. Manning B. H., Mayer D. J. The central nucleus of the amygdala contributes to the production of morphine antinociception in the formalin test. Pain. 63:1995;141-152.
109. Manning B. H., Morgan M. J., Franklin K. B. J. Morphine analgesia in the formalin test. Evidence for forebrain and midbrain sites of action Neuroscience. 63:1994;289-294.
110. Marglin S. H., Milano W. C., Mattie M. E., Reid L. R. PCP and conditioned place preferemces. Pharmacol. Biochem. Behav. 33:1989;281-283.
111. Martin, W. J.; Patrick, S. L.; Coffin, P. O.; Tsou, K., et al.: An examination of the central sites of action of cannabinoid-induced antinociception in the rat [special issue]. 1994 International Symposium on Cannabis and the Cannabinoids: Biopsychological and biomedical effects of cannabinoids: Therapeutic potentials. Life Sci. 56:2103-2109; 1995.
112. Mastrianni J. A., Abbott F. V., Kunos G. Activation of central μ-opioid receptors is involved in clonidine analgesia in rats. Brain Res. 479:1989;283-289.
113. Matthies B. K., Franklin K. B. J. Formalin pain is expressed in decerebrate rats but not attenuated by morphine. Eur. Neuropsychopharmacol. 51:1992;199-206.
114. Matthies B. K., Franklin K. B. J. Morphine analgesia in the formalin test in thalamic and decorticate rats. Soc. Neurosci. Abstr. 18:1992;683.
115. Matthies B. K., Franklin K. B. J. Effects of partial decortication on opioid analgesia in the formalin test. Behav. Brain Res. 67:1995;59-66.
116. Mello N. K., Mendelson J. H. Operant analysis of human drug self administration. Marihuana, alcohol, heroin and polydrug use Bozarth M. A. Methods of assessing the reinforcing properties of abused drugs. 1987;525-558 Springer Verlag, New York.
117. Milne R. J., Gamble G. D. Behavioral modification of bulbospinal serotenergic inhibition and morphine analgesia. Brain Res. 521:1990;167-174.
118. Milstein S. L., MacCannell K., Karr G., Clark S. Marijuana-produced changes in pain tolerance. Experienced and nonexperienced subjects. Int. Pharmacopsychiatry. 10:1975;177-182.
119. Moore J., Dundee J. W. Alterations in response to somatic pain associated with anaesthesia. VII. The effect of nine phenothiazine derivatives. Br. J. Anaesth. 33:1961;422-431.
120. Morgan M. J., Franklin K. B. J. 6-Hydroxydopamine lesions of the ventral tegmentum abolish D-amphetamine and morphine analgesia in the formalin test but not in the tail flick test. Brain Res. 519:1990;144-149.
121. Morgan M. J., Franklin K. B. J. Dopamine receptor subtypes and formalin test analgesia. Pharmacol. Biochem. Behav. 40:1991;317-322.
122. Moss D. E. L., Johnson R. L. Tonic analgesic effects of delta-9-tetrahydrocannabinol as measured with the formalin test. Eur. J. Pharmacol. 61:1980;313-315.
123. Murray R. M. Dependence on analgesics in analgesic nephropathy. Br. J. Addict. 68:1973;265-272.
124. Murray R. M. Minor analgesic abuse. The slow recognition of a public health problem Br. J. Addict. 75:1980;9-17.
125. Naruse T., Asami T. Intravenous self-administration of diazepam in rats. Eur. J. Pharmacol. 135:1987;365-373.
126. Negus S. S., Henriksen S. J., Mattox A., Pasternak G. W., Portoghese P. S. X., Takemori A. E., Weinger M. B., Koob G. F. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats. J. Pharmacol. Exp. Ther. 265:1993;1245-1252.
127. Noyes R. Jr., Brunk S. F., Avery D. H., Canter A. Psychologic effects of oral delta-9-tetrahydrocannabinol in advanced cancer patients. Comprehens. Psychiatry. 17:1976;641-646.
128. Oitzl M. S., Hasenohrl R. U., Huston J. P. Reinforcing effects of peripherally administered substance P and its C-terminal sequence pGlu6-SP6-11 in the rat. Psychopharmacology (Berlin). 100:1990;308-315.
129. Olmstead M. C., Franklin K. B. J. The development of a conditioned place preference to morphine. Effects of microinjections into various CNS sites Behav. Neurosci. 111:1997;1313-1323.
130. Ossipov M. H., Gebhart G. F. Light pentobarbital anaesthesia diminishes the antinociceptive potency of morphine administered intracranially but not intrathecally in the rat. Eur. J. Pharmacol. 97:1984;137-140.
131. Paalzow G. Analgesia produced by clonidine in mice and rats. J. Pharm. Pharmacol. 26:1974;361-363.
132. Palaoglu Ö, Ayhan I. H. The possible modulation of morphine analgesia by the supramolecular GABA receptor complex. Psychopharmacology (Berlin). 90:1986;244-246.
133. Pelissier T., Paeile C., Soto-Moyano R., Saavedra H., Hernandez A. Analgesia produced by intrathecal administration of the kappa opioid agonist U-50,488H, on formalin-evoked cutaneous pain in the rat. Eur. J. Pharmacol. 190:1990;287-293.
134. Pfeiffer A., Branti V., Herx A., Emrich H. M. Psychotomimesis mediated by K opiate receptors. Science. 233:1986;774-776.
135. Pickens R., Harris W. C. Self-administration of d-amphetamine by rats. Psychopharmacology (Berlin). 12:1968;158-163.
136. Pohorecky L. A., Shah P. Ethanol-induced analgesia. Life Sci. 41:1987;1289-1295.
137. Pomerleau O. F. Nicotine as a psychoactive drug. Anxiety and pain reduction Psychopharmacol. Bull. 22:1986;865-869.
138. Price D. D., Von der Gruen A., Miller J., Rafii A., Price C. A psychophysical analysis of morphine analgesia. Eur. Neuropsychopharmacology. 22:1985;261-2269.
139. Proudfit H. K., Levy R. A. Delimitation of neuronal substrate necessary for the analgesic action of baclofen and morphine. Eur. J. Pharmacol. 47:1978;159-166.
140. Reggio P. H., McGaughey G. B., Odear D. F., Setzman H. H., Compton D. R., Martin B. R. A rational search for the separation of psychoactivity and analgesia in cannabinoids. Pharmacol. Biochem. Behav. 40:1991;479-486.
141. Sadove M. S., Shulman M., Shigeru H., Fevold N. Analgesic effects of ketamine administration in subdissociative doses. Anesth. Analg. 50:1971;452-457.
142. Sahley T. L., Berntson G. G. Antinociceptive effect of central and systemic administration of nicotine in the rat. Psychopharmacology (Berlin). 65:1979;279-283.
143. Sandyk R. Anticholinergic induced analgesia. Possible role for cholinergic system in abnormal sensory symptoms in Parkinson's disease Postgrad. Med. J. 62:1986;749-751.
144. Satoh M., Kubota A., Iwama T., Wada T., Yasui M., Fujibayashi K., Takagai H. Comparison of analgesic potencies of Mu, Delta and Kappa agonists locally applied to various CNS regions relevant to analgesia in rats. Life Sci. 33:1983;689-692.
145. Sawynok J., Reid A. Neurotoxin-induced lesions to central serotonergic, noradrenergic and dopaminergic systems modify caffeine-induced antinociception in the formalin test and locomotor stimulation in rats. J. Pharmacol. Exp. Ther. 277:1996;646-653.
146. Semion I. Z., Nawrocka E., Slon J., Tartar A., Obuchowicz E., Golba K., Herman Z. S. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs. Pol. J. Pharmacol. Pharm. 42:1990;393-401.
147. Shekhar A., DiMiccio J. A. Defense reaction elicited by injection of GABA antagonists and synthesis inhibitors into the posterior hypothalamus in rats. Neuropharmacology. 26:1987;407-417.
148. Siegel R. K. Phencyclidine and ketamine intoxication. A study of four populations of recreational users Petersen R. C., Stillman R. C. Phencyclidine (PCP) abuse. An appraisal:1978;119-147 NIDA, Rockville, MD.
149. Skingle M., Hayes A. G., Tyers M. B. Antinociceptive activity of clonidine in the mouse, rat and dog. Life Sci. 31:1982;1123-1132.
150. Smith F. L., Yu D. S. L., Smith D. G., Leccese A. P., Lyness W. H. Dietary tryptophan supplements attenuate amphetamine self-administration in the rat. Pharmacol. Biochem. Behav. 25:1986;849-855.
151. Smith J. M. Abuse of antiparkinson drugs. A review of the literature J. Clin. Psychiatry. 41:1980;351-355.
152. Spyraki C., Fibiger H. C., Phillips A. G. Cocaine-induced place preference conditioning. Lack of effects of neuroleptics and 6-hydroxydopamine lesions Brain Res. 253:1982;195-203.
153. Stein C., Millan M. J., Shippenberg T. S., Peter K., Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J. Pharmacol. Exp. Ther. 248:1989;1269-1275.
154. Szostak C., Finlay J. M., Fibiger H. C. Intravenous self-administration of the short-acting benzodiazepine midazolam in the rat. Neuropharmacology. 26:1987;1673-1676.
155. Taber R. I., Latranyi M. B. Antagonism of the analgesic effect of opioid and nonopioid agents by p-chlorophenylalanine (PCPA). Eur. J. Pharmacol. 75:1981;215-222.
156. Tocco D. R., Maickel R. P. Analgesic activities of ampetamine isomers. Arch. Int. Pharmacodyn. Ther. 268:1984;25-31.
157. Tulunay F. C., Sparber S. B., Takemori A. E. The effect of dopaminergic stimulation and blockade on the nociceptive and antinociceptive responses of mice. Eur. J. Pharmacol. 33:1975;65-70.
158. van der Kooy D., Mucha R. F., O'Shaughnessy M., Bucenieks P. Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference. Brain Res. 243:1982;107-117.
159. Van Ree J. M., Slangen J. L., de Wied D. Intravenous self-administration of drugs in rats. J. Pharmacol. Exp. Ther. 204:1978;547-557.
160. Walker G. E., Yaksh T. L. Studies on the effects of intrathalamically injected DADL and morphine on nociceptive thresholds and electroencephalographic activity. A thalamic delta receptor syndrome Brain Res. 383:1986;1-14.
161. Wang F. S., Fujimoto J. M. Pentobarbital administered intracerebroventricularly antagonizes morphine-induced antinociception in mice. J. Pharmacol. Exp. Ther. 265:1993;1361-1368.
162. Webb S. S., Smith G. M., Evans W. O., Webb N. C. Toward the development of a potent, nonsedating, oral analgesic. Psychopharmacology (Berlin). 60:1978;25-28.
163. Werner T. E., Smith S. G., Davis W. M. A dose-response comparison between methadone and morphine self-administration. Psychopharmacology (Berlin). 47:1976;209-211.
164. Wiertelak E. P., Maier S. F., Watkins L. R. Cholecystokinin antianalgesia. Safety cues abolish morphine analgesia Science. 256:1992;830-833.
165. Wilson M. C., Hitomi M., Schuster C. R. Psychomotor stimulant self-administration as a function of dosage per injection in the rhesus monkey. Psychopharmacologia. 22:1971;271-281.
166. Winger G., Stitzer M. L., Woods J. H. Barbiturate-reinforced responding in rhesus monkeys. Comparisons of drugs with different durations of action J. Pharmacol. Exp. Ther. 195:1975;505-514.
167. Wise R. A. The role of reward pathways in the development of drug dependence. Pharmacol. Ther. 35:1987;227-263.
168. Woodrow K. M., Eltherington L. G. Feeling no pain. Alcohol as an analgesic Pain. 32:1988;159-163.
169. Woolverton W. L., Wessinger W. D., Balster R. L. Reinforcing properties of clonidine in rhesus monkeys. Psychopharmacology (Berlin). 77:1982;17-23.
170. Woolverton W. L. Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J. Pharmacol. Exp. Ther. 230:1984;678-683.
171. Yaksh T. L., Rudy T. A. Studies on the direct spinal action of narcotics in the production of analgesia in the rat. J. Pharmacol. Exp. Ther. 202:1977;411-428.
172. Yang J. C., Clark W. C., Dooley J. C., Mignogna F. V. Effect of intranasal cocaine on experimental pain in man. Anesth. Analg. 61:1982;358-361.
173. Yokel R. A., Wise R. A. Increased lever pressing for amphetamine in rats. Implications for a dopamine theory of reward Science. 187:1975;547-549.
174. Young A. M., Woods J. H. Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories. J. Pharmacol. Exp. Ther. 218:1981;720-727.
175. Zemlan F. P., Kow L., Pfaff D. W. Analgesia after lesions of nucleus reticularis magnocellularis. Differential effect on supraspinal vs. spinal pain reflexes Eur. Neuropsychopharmacol. 18:1984;221-237.
176. Zhang Z., Pasternak G. W. Opiates and enkephalins. A common binding site mediates their analgesic actions in rats Life Sci. 29:1981;843-851.